New Directors of the Centre for Responsive HealthTech Innovation announced

Professors Alejandro Frangi and David Jayne have been appointed as the first joint Directors of the new Centre for Responsive HealthTech Innovation.

The Centre is a partnership initiative between the University of Leeds and the Leeds Teaching Hospital NHS Trust and will bring together scientists, clinicians and industry partners to deliver world-leading, cross-disciplinary research, driven by clinical grand challenges, that ultimately delivers value-based innovation to improve outcomes for patients and populations.

The Directors, together with a cross-institutional Executive Leadership Team and Research and Innovation support from Saeeda Bashir, will deliver an exciting programme of research based on a vision to transform Leeds into one of the most connected, innovation-driven, and challenge-led HealthTech ecosystems that drive global transformations in healthcare. 

It will have value-based innovation at its heart and respond rapidly to changing socio-economic needs, accelerating the transformation of innovation to deliver equitable, sustainable and responsible healthcare for all.

Professor Alejandro Frangi

Professor Alejandro (Alex) Frangi graduated in Electrical Engineering from Universitat Politènica de Catalunya, Barcelona, completing his PhD in Radiological Imaging Sciences at Utrecht University Medical Centre, The Netherlands. He held previous academic appointments in Zaragoza, Barcelona, and Sheffield. 

Alex joined the University of Leeds in 2018 as Diamond Jubilee Chair in Computational Medicine with joint appointments in the Schools of Computing and Medicine.

In 2019, he was awarded a Royal Academy of Engineering Chair in Emerging Technologies. He works across computational medical imaging and computational physiology.

He holds honorary appointments in KU Leuven and Shenzhen University. He brings an international research profile in computational medicine, machine learning in imaging, and in silico clinical trials.

He served as Dean of the Escola Superior Politècnica (Universitat Pompeu Fabra), serves as Associate Editor of Prog Biomed Eng, IEEE Trans Medical Imaging, and Medical Image Analysis journals, and is IEEE, SPIE and EAMBES Fellow.

Professor David Jayne

Professor David Jayne graduated from University of Wales College of Medicine and undertook his surgical training in Manchester, Singapore and Leeds.

He was appointed Professor of Surgery in 2011, National Institute for Health Research (NIHR) Research Professor in 2012, and Bowel Cancer UK and Royal College of Surgeons England (RCS Eng) Chair of Surgery in 2018.

He is an Honorary Consultant Colorectal Surgeon at Leeds Teaching Hospitals NHS Trust and University Associate Dean for the St James’s University Hospital and CAH campuses. 

As Clinical Director, David brings a world-leading clinical research track record in the development and evaluation of new surgical technologies.

He is Clinical Director for the Leeds NIHR MedTech Co-operative in Surgical Technologies, the Leeds NIHR Global Health Research Group in Surgical Technologies, and the RCS Eng. Surgical Trials Centre.

He has held leadership roles with several national funding bodies and currently serves on the NIHR i4i, NIHR Advanced Fellowship, and NIHR IAT committees.

This article was originally published by the University of Leeds. For more information, please contact the University of Leeds press office: